| 2026-08-26 | Hochstufung | UBS | Neutral → Buy |
| 2026-07-20 | Bestätigt | TD Cowen | Buy |
| 2026-06-29 | Resumed | Wells Fargo | Equal Weight |
| 2026-05-29 | Bestätigt | TD Cowen | Buy |
| 2026-04-15 | Herabstufung | Goldman | Neutral → Sell |
| 2026-03-20 | Hochstufung | Jefferies | Underperform → Hold |
| 2026-03-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2026-02-19 | Bestätigt | TD Cowen | Buy |
| 2026-01-13 | Eingeleitet | Raymond James | Mkt Perform |
| 2026-01-09 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-12-16 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-11-06 | Bestätigt | TD Cowen | Hold |
| 2025-08-08 | Bestätigt | TD Cowen | Hold |
| 2025-07-16 | Herabstufung | BNP Paribas Exane | Neutral → Underperform |
| 2025-07-14 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-07-09 | Herabstufung | Goldman | Buy → Neutral |
| 2025-07-08 | Hochstufung | KeyBanc Capital Markets | Underweight → Sector Weight |
| 2025-06-17 | Herabstufung | KeyBanc Capital Markets | Sector Weight → Underweight |
| 2025-05-23 | Hochstufung | Northland Capital | Under Perform → Market Perform |
| 2025-05-16 | Herabstufung | Northland Capital | Market Perform → Under Perform |
| 2025-04-25 | Hochstufung | Northland Capital | Under Perform → Market Perform |
| 2025-04-23 | Herabstufung | Guggenheim | Neutral → Sell |
| 2025-04-23 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-02-20 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2025-02-20 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-02-20 | Herabstufung | Northland Capital | Market Perform → Under Perform |
| 2025-01-08 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-12-17 | Hochstufung | Goldman | Sell → Buy |
| 2024-11-20 | Hochstufung | Guggenheim | Sell → Neutral |
| 2024-11-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-11-07 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-11-07 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-11-07 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2024-11-07 | Bestätigt | TD Cowen | Hold |
| 2024-10-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2024-09-17 | Herabstufung | Jefferies | Hold → Underperform |
| 2024-09-04 | Eingeleitet | Jefferies | Hold |
| 2024-08-29 | Eingeleitet | William Blair | Mkt Perform |
| 2024-08-08 | Bestätigt | TD Cowen | Buy |
| 2024-07-23 | Bestätigt | ROTH MKM | Neutral |
| 2024-07-17 | Herabstufung | DZ Bank | Hold → Sell |
| 2024-07-08 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-06-25 | Bestätigt | Canaccord Genuity | Hold |
| 2024-06-25 | Bestätigt | JP Morgan | Overweight |
| 2024-06-25 | Bestätigt | Scotiabank | Sector Perform |
| 2024-05-13 | Herabstufung | Susquehanna | Positive → Neutral |
| 2024-05-09 | Bestätigt | TD Cowen | Buy |
| 2024-02-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-01-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2024-01-16 | Eingeleitet | Canaccord Genuity | Hold |
| 2023-12-19 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-18 | Herabstufung | Goldman | Neutral → Sell |
| 2023-11-21 | Eingeleitet | Mizuho | Buy |
| 2023-11-06 | Herabstufung | HSBC Securities | Buy → Hold |
| 2023-11-06 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-11-03 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-11-02 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-11-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-11-02 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2023-11-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-11-02 | Herabstufung | Truist | Buy → Hold |
| 2023-10-20 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-10-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-10-20 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-20 | Herabstufung | Goldman | Buy → Neutral |
| 2023-10-20 | Herabstufung | Johnson Rice | Accumulate → Hold |
| 2023-10-20 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2023-10-20 | Herabstufung | ROTH MKM | Buy → Neutral |
| 2023-08-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-05-05 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-04-13 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-05 | Eingeleitet | Janney | Buy |
| 2023-04-03 | Resumed | Morgan Stanley | Equal-Weight |
| 2023-03-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-03-02 | Eingeleitet | Scotiabank | Sector Perform |
| 2022-12-23 | Eingeleitet | Daiwa Securities | Neutral |
| 2022-12-14 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-12-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-12-05 | Bestätigt | Cowen | Outperform |
| 2022-11-15 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-08 | Hochstufung | Northland Capital | Under Perform → Market Perform |
| 2022-08-05 | Eingeleitet | Barclays | Equal Weight |
| 2022-06-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-05-02 | Resumed | Truist | Buy |
| 2022-04-14 | Eingeleitet | Stephens | Overweight |
| 2022-02-16 | Bestätigt | BMO Capital Markets | Outperform |
| 2022-02-16 | Bestätigt | Canaccord Genuity | Hold |
| 2022-02-16 | Bestätigt | JP Morgan | Overweight |
| 2022-02-16 | Bestätigt | Susquehanna | Positive |
| 2022-02-16 | Bestätigt | UBS | Neutral |
| 2022-02-03 | Hochstufung | Needham | Hold → Buy |
| 2022-01-24 | Bestätigt | Truist | Buy |
| 2022-01-13 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-01-10 | Bestätigt | Goldman | Buy |
| 2022-01-10 | Hochstufung | UBS | Sell → Neutral |
| 2021-11-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-23 | Eingeleitet | Wells Fargo | Overweight |
| 2021-10-20 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-10-01 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-09-01 | Eingeleitet | Wolfe Research | Outperform |
| 2021-08-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-08-03 | Hochstufung | Johnson Rice | Hold → Accumulate |
| 2021-06-25 | Eingeleitet | Citigroup | Neutral |
| 2021-06-25 | Eingeleitet | Stephens | Overweight |
| 2021-06-03 | Eingeleitet | Guggenheim | Buy |
| 2021-05-20 | Hochstufung | Goldman | Neutral → Buy |
| 2021-05-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-05-04 | Bestätigt | Cowen | Outperform |
| 2021-04-22 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-04-06 | Eingeleitet | Tudor Pickering | Buy |
| 2021-04-01 | Eingeleitet | BofA Securities | Neutral |
| 2021-03-19 | Hochstufung | Susquehanna | Neutral → Positive |
| 2021-01-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-01-12 | Eingeleitet | Truist | Buy |
| 2021-01-07 | Herabstufung | Susquehanna | Positive → Neutral |
| 2020-12-11 | Eingeleitet | Piper Sandler | Overweight |
| 2020-11-03 | Bestätigt | B. Riley Securities | Buy |
| 2020-11-03 | Herabstufung | Northland Capital | Market Perform → Under Perform |
| 2020-11-03 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-10-27 | Herabstufung | UBS | Neutral → Sell |
| 2020-10-16 | Hochstufung | Goldman | Sell → Neutral |
| 2020-10-15 | Eingeleitet | Susquehanna | Positive |
| 2020-09-23 | Eingeleitet | B. Riley FBR | Buy |
| 2020-08-03 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2020-06-25 | Herabstufung | Goldman | Neutral → Sell |
| 2020-05-27 | Eingeleitet | Johnson Rice | Accumulate |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | Needham | Buy → Hold |
| 2020-03-25 | Eingeleitet | Barclays | Equal Weight |
| 2020-02-20 | Bestätigt | Needham | Buy |
| 2020-01-27 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2019-12-02 | Eingeleitet | Needham | Buy |
| 2019-08-22 | Herabstufung | UBS | Buy → Neutral |
| 2019-06-27 | Bestätigt | Cascend Securities | Buy |